We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$16.1B
Cap. Flow %
-2.59%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.71%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIK icon
2926
Anika Therapeutics
ANIK
$288M
-8,998
Closed -$215K
AOK icon
2927
iShares Core Conservative Allocation ETF
AOK
$795M
-569
Closed -$19K
ASHR icon
2928
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
-66,000
Closed -$1.79M
ATOS icon
2929
Atossa Therapeutics
ATOS
$24M
-2,293
Closed -$29K
BROS icon
2930
Dutch Bros
BROS
$9.01B
-7,000
Closed -$219K
CKPT
2931
DELISTED
Checkpoint Therapeutics
CKPT
-5,900
Closed -$62K
CLSD
2932
DELISTED
Clearside Biomedical
CLSD
-1,547
Closed -$27K
CPF icon
2933
Central Pacific Financial
CPF
$1B
-19,699
Closed -$408K
CXM icon
2934
Sprinklr
CXM
$1.57B
-72,997
Closed -$674K
DIBS icon
2935
1stdibs.com
DIBS
$161M
-94,865
Closed -$597K
DLO icon
2936
dLocal
DLO
$4.3B
-705,786
Closed -$14.5M
DSGN icon
2937
Design Therapeutics
DSGN
$906M
-280,120
Closed -$4.68M
EPIX
2938
DELISTED
ESSA Pharma
EPIX
-44,832
Closed -$82K
FPAY
2939
DELISTED
FlexShopper
FPAY
-27,700
Closed -$52K
FSV icon
2940
FirstService
FSV
$6.15B
-1,799,011
Closed -$214M
GBDC icon
2941
Golub Capital BDC
GBDC
$3.44B
-12,000
Closed -$149K
GFI icon
2942
Gold Fields
GFI
$35.3B
-9,430,217
Closed -$76.3M
GOCO
2943
DELISTED
GoHealth
GOCO
-7,400
Closed -$40K
HLN icon
2944
Haleon
HLN
$43B
-14,354,094
Closed -$87.4M
HOFV
2945
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
-3,618
Closed -$44K
IPI icon
2946
Intrepid Potash
IPI
$487M
-73,394
Closed -$2.91M
ISPO
2947
DELISTED
Inspirato
ISPO
-1,539
Closed -$73K
IZEA icon
2948
IZEA Worldwide
IZEA
$52.9M
-14,275
Closed -$41K
KALA icon
2949
KALA BIO
KALA
$16.6M
-36
Closed -$20K
KRUS icon
2950
Kura Sushi USA
KRUS
$636M
-3,620
Closed -$267K

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.